Activation of the PI3K/AKT/mTOR pathway is recurrent in both B-cell lymphomas and TCLs and appears to be related to p53, HIF-1α, and MYC [36,37,38,39,128,142]. This evidence concerns the gene AKT1 and B-cell non-Hodgkin lymphoma.